Jan Taprogge

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Computed Tomography

Combination Therapy

Top Venues

Journal of radiological protection : official journal of the Society for Radiological Protection

European journal of nuclear medicine and molecular imaging

Physics in medicine and biology

Royal Marsden NHS Foundation Trust

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Royal Marsden NHS Foundation Trust Jun 04 2018

United Kingdom

Senior Radioisotope and Imaging Physicist :: Radioisotope Physics

St. George's University NHS FT Sep 21 2015 - Jun 01 2018

United Kingdom

Trainee Clinical Scientist :: Medical Physics & Clinical Engineering

Publications

Jan Taprogge, Alex Vergara-Gil, Francesca Leek, Carla Abreu, Lenka Vávrová, Lily Carnegie-Peake, Sarah Schumann, Uta Eberlein, Michael Lassmann, Tino Schurrat, Markus Luster, Frederik A Verburg, Delphine Vallot, Lavinia Vija, Frédéric Courbon, Kate Newbold, Manuel Bardiès, Glenn Flux
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project. European journal of nuclear medicine and molecular imaging (2023)
Johan Gustafsson, Jan Taprogge
Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapy. Physics in medicine and biology 67 (2) (2022)
Jan Taprogge, Lily Carnegie-Peake, Iain Murray, Jonathan I Gear, Glenn D Flux
Adjustment of the iodine ICRP population pharmacokinetic model for the use in thyroid cancer patients after thyroidectomy. Journal of radiological protection : official journal of the Society for Radiological Protection 41 (4) (2021)
Jan Taprogge, Francesca Leek, Tino Schurrat, Johannes Tran-Gia, Delphine Vallot, Manuel Bardiès, Uta Eberlein, Michael Lassmann, Susanne Schlögl, Alex Vergara Gil, null null, Glenn D Flux
Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project. EJNMMI physics 7 (1) (2020)